The TGF-β1 treatment induces a significant increase in several pro-inflammatory cytokines in NHBE ALI cultures with significant increases in levels of IL-6, GM-CSF, and MCP-1 (Fig. 5A and B). This evidence concerns the gene IL6 and acute respiratory distress syndrome.